| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d12552072c7764a8234250c4abdc1e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08 |
| filingDate |
2003-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2c84e33f998c25d0b171e8162fec2db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d04368a7878481bf86df46c8b822f52f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_686f1816a2661b3066cc2d66a81948b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6742cd2e2ce2ce4c24698f8649a0fa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e7beb1d180abb9b5cdc01a72ecf6098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77deaa05c4e3fbdda08e94454ca31f96 |
| publicationDate |
2003-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003170704-A1 |
| titleOfInvention |
Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| abstract |
The present inventions relates to substances which are capable of controlling the inclusion of exon (10) of the tau gene. The substances can reverse “wrong” tau splicing pattern and. Since “wrong” tau splicing patterns are associated with tauopathies that cause dementia, the substances can be used as therapeutic agents. The invention also provides a method for testing substances that control tau exon (10) inclusion. The method is suitable for a high throughput screening. Additional products which are useful for changing tau exon (10) expression or for performing the test method are described as well. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014220036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513701-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016151523-A1 |
| priorityDate |
1999-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |